Cargando…

The continuous counting of phosphorus-32 from transplanted rat tumours and the effects of radiosensitisers and radioprotective agents.

Detalles Bibliográficos
Autores principales:	Calcutt, G., Bullen, M. A., Marshall, D. H., Godden, T. J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1967
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008115/ https://www.ncbi.nlm.nih.gov/pubmed/6028093

Ejemplares similares

Radiosensitisation and radioprotection by BSO and WR-2721: the role of oxygenation.
por: Durand, R. E., et al.
Publicado: (1989)

Cinnarizine and flunarizine improve the tumour radiosensitisation induced by erythrocyte transfusion in anaemic mice.
por: Wood, P. J., et al.
Publicado: (1989)

Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.
por: Rojas, A., et al.
Publicado: (1993)

Bosutinib high density lipoprotein nanoformulation has potent tumour radiosensitisation effects
por: Dehghankelishadi, Pouya, et al.
Publicado: (2023)

Inhibitory effect of endostatin gene therapy combined with phosphorus-32 colloid on tumour growth in Wistar rats
por: Gao, Huiqi, et al.
Publicado: (2016)

Radiosensitisation of Hepatocellular Carcinoma Cells by Vandetanib
por: Znati, Sami, et al.
Publicado: (2020)

Hydrogen as a New Class of Radioprotective Agent
por: Qian, Liren, et al.
Publicado: (2013)

Substituted Piperazines as Novel Potential Radioprotective Agents
por: Filipova, Alzbeta, et al.
Publicado: (2020)

Sulphydryl Groups and Tumour Induction by Chemical Agents
por: Calcutt, G.
Publicado: (1961)

Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers
por: Liew, Lydia P., et al.
Publicado: (2023)

Melatonin and MitoEbselen-2 Are Radioprotective Agents to Mitochondria
por: Shimura, Tsutomu, et al.
Publicado: (2022)

Intrinsic radiosensitivity of human pancreatic tumour cells and the radiosensitising potency of the nitric oxide donor sodium nitroprusside.
por: Verovski, V. N., et al.
Publicado: (1996)

Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies
por: Diaz Miqueli, A, et al.
Publicado: (2009)

Radioprotective Effect of Thymoquinone in X-irradiated Rats
por: El-Benhawy, Sanaa A., et al.
Publicado: (2021)

The role of apoptotic cell death in the radiosensitising effect of gemcitabine
por: Pauwels, B, et al.
Publicado: (2009)

The role of mitochondrial function in gold nanoparticle mediated radiosensitisation
por: Taggart, Laura E, et al.
Publicado: (2014)

Cell cycle specific radiosensitisation by the disulfiram and copper complex
por: Tesson, Mathias, et al.
Publicado: (2017)

Metformin is a metabolic modulator and radiosensitiser in rectal cancer
por: Buckley, Croí E., et al.
Publicado: (2023)

The relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell lines
por: Pauwels, Bea, et al.
Publicado: (2006)

H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma
por: Zhang, Wenyan, et al.
Publicado: (2018)

Radioprotective agents to prevent cellular damage due to ionizing radiation
por: Smith, Tyler A., et al.
Publicado: (2017)

Molecular Hydrogen as a Potential Clinically Applicable Radioprotective Agent
por: Hirano, Shin-ichi, et al.
Publicado: (2021)

La radioprotection
por: Bonet-Maury, P
Publicado: (1969)

The Effects of Tumour Initiating Agents on Mouse Skin Sulphydryl Levels
por: Calcutt, G., et al.
Publicado: (1962)

Clinical Assessment of Tetra-sodium 2-Methyl-1: 4-Naphthohydroquinone Diphosphate as a Radiosensitiser in the Radiotherapy of Malignant Tumours
por: Mitchell, J. S.
Publicado: (1953)

Radioprotective potential of histamine on rat small intestine and uterus
por: Carabajal, E., et al.
Publicado: (2012)

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers
por: Harrington, K J, et al.
Publicado: (2011)

Cytotoxicity and radiosensitising activity of synthesized dinitrophenyl derivatives of 5-fluorouracil
por: Abdi, Khosrou, et al.
Publicado: (2012)

Titanium Dioxide Nanoparticles as Radiosensitisers: An In vitro and Phantom-Based Study
por: Youkhana, Esho Qasho, et al.
Publicado: (2017)

Low-energy electrons transform the nimorazole molecule into a radiosensitiser
por: Meißner, Rebecca, et al.
Publicado: (2019)

Bound Electron Enhanced Radiosensitisation of Nimorazole upon Charge Transfer
por: Kumar, Sarvesh, et al.
Publicado: (2022)

Borane-protected phosphines are redox-active radioprotective agents for endothelial cells
por: Crowe, Megan E., et al.
Publicado: (2015)

Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine.
por: Stratford, I. J., et al.
Publicado: (1988)

Exercices de radioprotection
por: Ammerich, Marc
Publicado: (2019)

Congrès de radioprotection
Publicado: (1971)

Radioprotection et radiothérapie
Publicado: (1975)

Manuel de radioprotection
por: CERN. Geneva
Publicado: (1983)

NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel
por: Negishi, T, et al.
Publicado: (2006)

VITAMIN A AND ENDOCHONDRAL OSSIFICATION IN THE RAT AS INDICATED BY THE USE OF SULFUR-35 AND PHOSPHORUS-32
por: Dziewiatkowski, Dominic D.
Publicado: (1954)

VITAMIN D AND ENDOCHONDRAL OSSIFICATION IN THE RAT AS INDICATED BY THE USE OF SULFUR-35 AND PHOSPHORUS-32
por: Dziewiatkowski, Dominic D.
Publicado: (1954)

Cannot write session to /tmp/vufind_sessions/sess_9308at4bma07c8mvskn4ktvrme